MDA-MB-231  Xenografts

 

Rincon Bio performs MDA-MB-231 xenograft models to test efficacy of preclinical therapies.  Please see below for additional information or to request a quote.  

Breast

MDA-MB-231 cells were isolated from a 51 year old female with adenocarcinoma of the breast. 

Oncogene

The cell line is aneuploid female (modal number = 64, range = 52 to 68), with chromosome counts in the near-triploid range. Normal chromosomes N8 and N15 were absent.  Ref

in vivo

Forms tumors in nude and BALB/c mice

Used in xenografts to test the efficacy of novel cancer therapeutics 

Request Quote

Receive a quote within one business day

Rincon Bio Growth Curve

MDA-MB-231.jpg

MDA-MB-231 cells implanted in nude mice

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We are easy to work with.  And we take a personal interest in our clients and their studies.